New Frontiers in Personalized Medicine: Cardiovascular Research & Clinical Care
Event Speaker(s)
Michael Bristow, M.D., Ph.D., CEO, Chief Science and Medical Officer, ARCA Biopharma
Michael Caldwell, M.D., Ph.D., FACS, Director, Wound Healing Program, Marshfield Clinic Topic: Pharmacogenetic Approaches to Warfarin Dosing
Pierre Cassigneul, President and CEO, XDx
Victor Dzau, M.D., President and CEO, Duke University Health System and Chancellor for Health Affairs, Duke University
Jennifer Van Eyk, Ph.D., Director, The Johns Hopkins NHLBI Proteomics Center
Geoffrey Ginsburg, M.D., Ph.D., Director, Center for Genomic Medicine, Institute for Genome Sciences and Policy, Duke University
Richard Katz, M.D., Bloedorn Professor of Medicine and Division Director, the George Washington University Richard B. and Lynne V. Cheney Cardiovascular Institute
Bruce Korf, M.D., Ph.D., Chair of the UAB Department of Genetics, University of Alabama at Birmingham
Jack Lewin, M.D., CEO, American College of Cardiology
Timothy McCaffrey, Ph.D., Professor of Medicine and Director, Division of Genomic On Medicine, the George Washington University
Christopher Newton-Cheh, M.D., MPH, Cardiologist, Massachusetts General Hospital
Andrew Plump, M.D., Ph.D., Vice President and Cardiovascular Disease Franchise Worldwide Basic Research Head, Merck
Ben Salisbury, Ph.D., Vice President, Clinical Genetics, PGxHealth
Steve Rosenberg, Ph.D., Chief Science Officer, CardioDx
Vicki Seyfert-Margolis, Ph.D., Senior Advisor, Science Innovation and Policy, Office of the Chief Scientist, Office of the Commissioner, Food and Drug Administration
Susan Shurin, M.D., Acting Director, National Heart, Lung, and Blood Institute, National Institutes of Health
John Spertus, M.D., MPH, Lauer/Missouri Endowed Chair and Professor, University of Missouri – Kansas City and Clinical Director of Outcomes Research, St. Luke’s Mid America Heart Institute
Jean-Claude Tardif, M.D., Professor of Medicine, Director of the Research Centre, Montreal Heart Institute
Russell Teagarden, Ph.D., Vice President, Clinical Practices and Therapeutics, Medco Health Solutions, Inc.
Jay Wohlgemuth, M.D., Vice President, Science and Innovation, Quest Diagnostics Nichols Institute
|
Last Updated January 2012 |
Get Email Alerts
Twitter
Facebook
YouTube